Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
10/23/1996 | CN1134148A Antithrombotic amidinophenylalanine and amidinopyridylalanine derivs |
10/23/1996 | CN1133834A Cinnamic acid derivative |
10/22/1996 | US5567814 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
10/22/1996 | US5567804 Human leucocyte elastase inhibitor; antioxidant |
10/22/1996 | US5567408 YIGSR peptide radiopharmaceutical applications |
10/22/1996 | CA1338659C Method of healing wounds in horses |
10/17/1996 | WO1996032468A2 Bioprocess for production of dipeptide based compounds |
10/17/1996 | WO1996032415A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
10/17/1996 | WO1996032410A1 Plant cell growth factors |
10/17/1996 | WO1996032409A1 Plant cell growth factor |
10/17/1996 | WO1996032408A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor |
10/17/1996 | WO1996032380A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
10/17/1996 | WO1996020725A3 Peptide, peptide analog and amino acid analog protease inhibitors |
10/17/1996 | DE19512484A1 Kohlenhydratmodifizierte Cytostatika Carbohydrate-modified cytostatics |
10/17/1996 | CA2216996A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
10/17/1996 | CA2212356A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor |
10/16/1996 | EP0737232A1 Modular design and synthesis of aminimide containing molecules |
10/16/1996 | EP0737204A1 Cs-1 peptidomimetics, compositions and methods of using the same |
10/16/1996 | CN1133563A Novel tripeptides useful in immune and CNS therapy |
10/15/1996 | US5565568 Useful in treatment or prevention of a physiological disorder associated with an excess of tachykinins |
10/15/1996 | US5565430 Azaaspartic acid analogs as interleukin-1β converting enzyme inhibitors |
10/15/1996 | US5565429 Human leucocyte elastase inhibitors; emphysema; antiarthritic agents; rheumatic diseases |
10/15/1996 | US5565426 Anti-aggregation, inhibtion of blood clotting |
10/15/1996 | US5565418 Retroviral protease inhibiting compounds |
10/10/1996 | WO1996031532A1 Sugar-modified cytostatics |
10/10/1996 | WO1996031527A1 Protease inhibiting succinic acid derivatives |
10/10/1996 | WO1996031525A2 Inhibitors of farnesyl-protein transferase |
10/10/1996 | WO1996031504A1 Thrombin inhibitors |
10/10/1996 | WO1996031227A1 Phosphonates, biphosphonates and pharmaceutical compositions containing them |
10/10/1996 | WO1996031214A1 2-acylaminopropanamides as tachykinin receptor antagonists |
10/10/1996 | WO1996023771A3 Platelet aggregation inhibitors |
10/10/1996 | CA2217461A1 2-acylaminopropanamides as tachykinin receptor antagonists |
10/10/1996 | CA2217164A1 Sugar-modified cytostatics |
10/10/1996 | CA2216859A1 Thrombin inhibitors |
10/10/1996 | CA2216654A1 Inhibitors of farnesyl-protein transferase |
10/09/1996 | EP0736039A1 Compounds with growth hormone releasing properties |
10/09/1996 | EP0736038A1 Compounds with growth hormone releasing properties |
10/09/1996 | EP0736037A1 NOVEL INTERMEDIATES FOR THE SYNTHESIS OF L-ASPARTYL-D-$g(a)-AMINOALKANOYL-(S)-N-$g(a)-ALKYLBENZYL AMIDES USEFUL AS ARTIFICIAL SWEETENERS |
10/09/1996 | EP0736036A1 Kininogen inhibitors |
10/09/1996 | EP0735894A1 Composition and methods to improve neural outcome |
10/09/1996 | EP0735893A1 Alteration of immune response using pan dr-binding peptides |
10/09/1996 | EP0678089B1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
10/09/1996 | EP0678088B1 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
10/09/1996 | EP0528820B1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase |
10/09/1996 | CN1133048A Oligopeptides derived from C-reactive protein fragments |
10/09/1996 | CN1133047A Therapeutic peptide derivatives |
10/09/1996 | CN1132756A Antiviral ethers of aspartate protease substrate isosteres |
10/08/1996 | US5563156 Anticoagulants, antiasthma agents |
10/08/1996 | US5563121 Phosphinate methylene ammonium linkage |
10/08/1996 | US5563041 Method for determining platelet aggregation |
10/08/1996 | CA1338633C Dipeptides and process |
10/03/1996 | WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
10/03/1996 | WO1996030397A1 New peptides with immunomodulatory effects |
10/03/1996 | WO1996030396A1 β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS |
10/03/1996 | WO1996030395A2 Cysteine protease inhibitor |
10/03/1996 | WO1996030378A1 Bisphosphonic acid derivatives |
10/03/1996 | WO1996030353A1 Reversible protease inhibitors |
10/03/1996 | WO1996030332A1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
10/03/1996 | WO1996030035A1 β-SHEET MIMETICS AND USE THEREOF AS INHIBITORS OF BIOLOGICALLY ACTIVE PEPTIDES OR PROTEINS |
10/03/1996 | WO1995027727A3 Process for peptide segment condensation |
10/03/1996 | CA2216151A1 Reversible protease inhibitors |
10/03/1996 | CA2215720A1 .beta.-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins |
10/03/1996 | CA2215211A1 Cysteine protease inhibitor |
10/03/1996 | CA2189656A1 New peptides with immunomodulatory effects |
10/02/1996 | EP0735019A2 Retroviral protease inhibitors |
10/02/1996 | EP0734391A1 Pna-dna-pna chimeric macromolecules |
10/02/1996 | EP0480071B1 S-(lower fatty acid)-substituted glutathione derivative |
10/02/1996 | CN1132504A Inhibitor of inhibiting generation of beta-amyloid |
10/01/1996 | US5561220 Technetium-99m labeled peptides for imaging inflammation |
10/01/1996 | US5561146 Modified guanidino and amidino thrombin inhibitors |
10/01/1996 | US5561113 Analgesics; antiiflammatory agents; gastrointestinal, urogenital and nervous system(cns) disorders; asthma; antiallergens |
10/01/1996 | US5561112 Pseudopeptide isosteres of gly-asp and their use as antithrombic agents |
09/26/1996 | WO1996029313A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease |
09/26/1996 | WO1996029304A1 Nonpeptides as tachykinin antagonists |
09/26/1996 | WO1996029088A1 Novel piperazine derivatives as type il-1 receptor antagonists |
09/26/1996 | WO1996022760A3 Antagonists of alpha-melanocyte stimulating hormone and methods based thereon |
09/26/1996 | CA2211191A1 Nonpeptides as tachykinin antagonists |
09/25/1996 | EP0733642A1 Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions |
09/25/1996 | EP0733641A1 Method for crystallizing alpha-l-aspartyl-l-phenylalanine methyl ester |
09/25/1996 | EP0733213A1 Process for the production of combinatorial compound libraries |
09/25/1996 | EP0733060A1 Metal chelators |
09/25/1996 | EP0732944A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
09/25/1996 | EP0674513B1 Retroviral protease inhibiting compounds |
09/25/1996 | CN1131942A HIV protease inhibitors |
09/25/1996 | CN1131939A Oxidizer carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and antitumor agents |
09/21/1996 | CA2172022A1 Method for crystallizing alpha-l-aspartyl-l-phenylalanine methyl ester |
09/19/1996 | WO1996028465A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
09/19/1996 | WO1996028464A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
09/19/1996 | WO1996028463A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
09/19/1996 | WO1996028462A1 17-difluoromethylene-oestratrienes |
09/19/1996 | WO1995010628A3 Signal transduction via cd28 |
09/19/1996 | DE19509729A1 17-Difluormethylen-Estratriene 17-difluoromethylene estratrienes |
09/19/1996 | CA2449296A1 Modulators of amyloid aggregation |
09/19/1996 | CA2215201A1 17-difluoromethylene-estratrienes |
09/19/1996 | CA2215061A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
09/19/1996 | CA2215025A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
09/19/1996 | CA2215022A1 Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
09/18/1996 | EP0732399A2 Chymotrypsin-like proteases and their inhibitors |
09/18/1996 | EP0565631B1 Anti-viral compounds |
09/18/1996 | CN1131160A Process for producing alpha-L-aspartyldipeptide amide derivatives |